This federal contract award is for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml) 3ml, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,801.80, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of December 4, 2024. The contract is a firm fixed-price, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/4/25, 11:13 AM